Healthcare

in committee · New York · Assembly Jan 7, 2026

A 4296: Limits the off label use of antipsychotic drugs on elderly patients with dementia

Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.

Topics ✗ HealthcareOpposes HealthcareBill explicitly restricts off-label antipsychotic drug use on elderly dementia patients, limiting a healthcare practice per its summary and professional misconduct provision.90% confidence

Track

vetoed · New York · Assembly Dec 19, 2025

A 565: Relates to prohibiting the establishment of new for-profit hospices

This bill (A 565) prohibits the establishment of new for-profit hospices and bans capacity increases for existing for-profit hospices. It applies to all approvals after the law takes effect, directly affecting for-profit hospice providers and their expansion plans. The law requires new hospice facilities to operate as non-profits and prevents existing for-profit hospices from growing their services. This represents a concrete change in healthcare regulation, restricting for-profit models in hospice care.

Topics ✗ HealthcareOpposes HealthcareProhibits new for-profit hospices and bans capacity increases, restricting for-profit healthcare market access in hospice services.95% confidence

Track

in committee · New York · Assembly Jan 7, 2026

A 7800: Prohibits the use of state funds for non-residents seeking an abortion or related procedures

Prohibits the use of state funds for non-residents seeking an abortion or any other procedure that results in the intentional termination of a pregnancy at any stage of gestation.

Topics ✗ Budget & TaxesOpposes Budget & TaxesRestricts state funding for abortion services, limiting government spending on this issue per bill's explicit prohibition of state funds for non-resident procedures.95% confidence ✗ HealthcareOpposes HealthcareProhibits state funding for abortion services, restricting access to reproductive healthcare for non-residents, directly aligning with 'restricts health coverage' and 'defunds' indicators.95% confidence

Sub-Topics Women's Health

Track

in committee · New York · Assembly Jan 7, 2026

A 7096: Requires that health services paid for by a school district for a student attending outside the district be no greater than the district's cost

Requires that health and welfare services and facilities paid by a school district for a student attending school outside the district be no greater than the district's cost.

Topics ✗ EducationOpposes EducationRestricts school district spending on health services for out-of-district students by capping costs, limiting expenditure on educational support services.85% confidence ✗ HealthcareOpposes HealthcareBill caps school district spending on health services for out-of-district students at district's cost, restricting coverage scope and limiting benefits beyond standard district expenses.90% confidence

Sub-Topics Student Health

Track

in committee · New York · Senate Jan 7, 2026

S 6501: Repeals sections 1 and 1-a of part FFF of chapter 56 of the laws of 2020

Relates to directing the department of health to remove the pharmacy benefit from the managed care benefit package; provides the pharmacy benefit under the fee for service program.

Topics ✗ HealthcareOpposes HealthcareBill removes pharmacy benefit from managed care package (which typically controls costs) and shifts to fee-for-service, likely increasing patient costs/access barriers without explicit coverage expansion.75% confidence

Sub-Topics Prescription Drugs

Track

in committee · New York · Senate Jan 7, 2026

S 732: Relates to prescribing opioids to a minor

Relates to prescribing opioids to a minor; prohibits practitioners from prescribing to a minor more than a seven day supply of any controlled substance containing an opioid; requires practitioners to obtain written parental consent before issuing a first prescription of a controlled substance containing an opioid to a minor; establishes exceptions.

Topics ✗ HealthcareOpposes HealthcareBill restricts opioid prescriptions to minors by limiting supply and requiring consent, limiting patient access to controlled substances under healthcare guidelines.90% confidence

Sub-Topics Substance Abuse

Track

in committee · New York · Senate Jan 7, 2026

S 1968: Prohibits the establishment, incorporation, construction, or increase in capacity of for-profit nursing homes

Prohibits the public health and health planning council and the commissioner of health from approving the establishment, incorporation, construction, or increase in capacity of for-profit nursing homes.

Topics ✗ HealthcareOpposes HealthcareBill prohibits for-profit nursing homes, restricting a sector of healthcare provision per its explicit language.95% confidence

Sub-Topics Long-Term Care Public Health

Track

in committee · New York · Senate Jan 7, 2026

S 7088: Relates to prohibiting mandatory immunization against the coronavirus

Prohibits mandatory immunization against the coronavirus; prohibits requiring immunization for attendance at school or day care, transportation, travel, entering public buildings, employment, nursing home residency or receiving government services; provides that no proof of vaccine shall be required or used; prohibits incentive for administering or receiving vaccination.

Topics ✗ HealthcareOpposes HealthcareProhibits mandatory vaccines, restricting public health measures and access to immunization programs, directly limiting a healthcare initiative.95% confidence

Sub-Topics Long-Term Care Public Health

Track

in committee · New York · Assembly Jan 7, 2026

A 7501: Adds tianeptine sodium to the list of Schedule II of controlled substances

This bill adds tianeptine sodium to New York's Schedule II list of controlled substances under public health law. Schedule II classification means it will require strict prescription controls and limit distribution due to its high potential for abuse and accepted medical use. The change directly affects healthcare providers who prescribe it, pharmacies that dispense it, and individuals using the substance. This policy shift formalizes existing regulatory restrictions on tianeptine sodium as a controlled substance.

Topics ✗ HealthcareOpposes HealthcareRestricts healthcare access by classifying tianeptine sodium under strict Schedule II controls, limiting prescriptions and distribution despite medical use.95% confidence

Sub-Topics Public Health

Track

in committee · New York · Senate Jan 7, 2026

S 3351: Adds tianeptine sodium to the list of Schedule II of controlled substances

This bill adds tianeptine sodium to New York's Schedule II controlled substances list, which includes drugs with high abuse potential but recognized medical uses (like certain opioids). It directly affects healthcare providers who prescribe it, pharmacies that dispense it, and patients who use it, requiring stricter controls such as special prescriptions and recordkeeping. The law amends the public health law to include tianeptine sodium in Schedule II, aligning its regulation with other high-risk medications. The change takes effect 90 days after enactment.

Topics ✗ HealthcareOpposes HealthcareRestricts healthcare access by imposing Schedule II controls on tianeptine sodium, requiring special prescriptions and recordkeeping for providers and patients.90% confidence

Sub-Topics Public Health Substance Abuse

Track